Joana C. Vasconcelos

2.0k total citations
34 papers, 905 citations indexed

About

Joana C. Vasconcelos is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology and Oncology. According to data from OpenAlex, Joana C. Vasconcelos has authored 34 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Ophthalmology and 5 papers in Oncology. Recurrent topics in Joana C. Vasconcelos's work include Retinal Diseases and Treatments (10 papers), Retinal Imaging and Analysis (9 papers) and Retinal and Optic Conditions (6 papers). Joana C. Vasconcelos is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Retinal Imaging and Analysis (9 papers) and Retinal and Optic Conditions (6 papers). Joana C. Vasconcelos collaborates with scholars based in United Kingdom, Canada and United States. Joana C. Vasconcelos's co-authors include Nikolaos V. Bardakos, R. N. Villar, A Toby Prevost, Satoshi Hori, Sobha Sivaprasad, Philip Hykin, Jayashree Ramu, Caroline Murphy, Ann Louise Kinmonth and Joanna Kelly and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PLoS Medicine.

In The Last Decade

Joana C. Vasconcelos

32 papers receiving 858 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Joana C. Vasconcelos 226 202 182 94 89 34 905
Connie Chen 292 1.3× 168 0.8× 259 1.4× 12 0.1× 42 0.5× 28 992
Yu‐Sheng Lin 61 0.3× 53 0.3× 154 0.8× 10 0.1× 72 0.8× 66 926
Shahnaz Khan 50 0.2× 42 0.2× 125 0.7× 14 0.1× 45 0.5× 30 816
Jones 89 0.4× 28 0.1× 248 1.4× 18 0.2× 56 0.6× 43 783
Selçuk Pala 199 0.9× 23 0.1× 259 1.4× 13 0.1× 30 0.3× 88 1.1k
Joanna Lovett 312 1.4× 16 0.1× 304 1.7× 20 0.2× 66 0.7× 26 2.6k
Joedo Prihartono 57 0.3× 38 0.2× 69 0.4× 7 0.1× 43 0.5× 113 696
Carsten A. Böger 58 0.3× 27 0.1× 273 1.5× 9 0.1× 87 1.0× 58 1.2k
Corran Roberts 73 0.3× 56 0.3× 165 0.9× 6 0.1× 11 0.1× 18 929
Ira Pande 45 0.2× 52 0.3× 171 0.9× 16 0.2× 371 4.2× 43 917

Countries citing papers authored by Joana C. Vasconcelos

Since Specialization
Citations

This map shows the geographic impact of Joana C. Vasconcelos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joana C. Vasconcelos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joana C. Vasconcelos more than expected).

Fields of papers citing papers by Joana C. Vasconcelos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joana C. Vasconcelos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joana C. Vasconcelos. The network helps show where Joana C. Vasconcelos may publish in the future.

Co-authorship network of co-authors of Joana C. Vasconcelos

This figure shows the co-authorship network connecting the top 25 collaborators of Joana C. Vasconcelos. A scholar is included among the top collaborators of Joana C. Vasconcelos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joana C. Vasconcelos. Joana C. Vasconcelos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clough, Jennifer, Joana C. Vasconcelos, James B. Canavan, et al.. (2025). Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE). BMJ Open. 15(1). e092733–e092733. 5 indexed citations
3.
Cope, Andrew P., Joana C. Vasconcelos, Andrew Filer, et al.. (2023). OP0130 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT (APIPPRA) TRIAL. Annals of the Rheumatic Diseases. 82. 86–86. 9 indexed citations
4.
Raman, Rajiv, Joana C. Vasconcelos, Ramachandran Rajalakshmi, et al.. (2022). Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectional screening study. The Lancet Global Health. 10(12). e1764–e1773. 44 indexed citations
5.
Pennington, Becky, Abualbishr Alshreef, Laura Flight, et al.. (2021). Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study. PharmacoEconomics. 39(8). 913–927. 6 indexed citations
6.
Hykin, Philip, A Toby Prevost, Sobha Sivaprasad, et al.. (2021). Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment. 25(38). 1–196. 12 indexed citations
7.
Hardeman, Wendy, Sally Pears, S. Vijay, et al.. (2020). Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: The VBI randomised controlled trial. PLoS Medicine. 17(3). e1003046–e1003046. 11 indexed citations
8.
9.
Kirkham, Bruce, Christopher Hall, Toby Garrood, et al.. (2016). Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis. Lara D. Veeken. 55(11). 1993–2000. 34 indexed citations
11.
Walter, Fiona M, A Toby Prevost, Joana C. Vasconcelos, et al.. (2013). Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study. British Journal of General Practice. 63(610). e345–e353. 56 indexed citations
12.
Kelly, John D., Tim Dudderidge, Keith Burling, et al.. (2012). Bladder Cancer Diagnosis and Identification of Clinically Significant Disease by Combined Urinary Detection of Mcm5 and Nuclear Matrix Protein 22. PLoS ONE. 7(7). e40305–e40305. 34 indexed citations
13.
Sena, Armando, et al.. (2012). Oral contraceptive use and clinical outcomes in patients with multiple sclerosis. Journal of the Neurological Sciences. 317(1-2). 47–51. 40 indexed citations
14.
Coles, Charlotte E., Emma Harris, Ellen M. Donovan, et al.. (2011). Evaluation of implanted gold seeds for breast radiotherapy planning and on treatment verification: A feasibility study on behalf of the IMPORT trialists. Radiotherapy and Oncology. 100(2). 276–281. 24 indexed citations
15.
Prevost, A Toby, et al.. (2010). A comparison of technologies used for estimation of body temperature. Physiological Measurement. 31(9). 1105–1118. 27 indexed citations
16.
Hori, Satoshi, et al.. (2010). Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer. Journal of Cancer Research and Clinical Oncology. 137(2). 235–241. 30 indexed citations
17.
Marteau, Theresa M., A Toby Prevost, Joana C. Vasconcelos, et al.. (2010). Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial. BMJ. 340(may13 2). c2138–c2138. 41 indexed citations
18.
Grant, Lisa, et al.. (2009). The role of a consultant radiologist—are patients still in the dark?. European Radiology. 19(10). 2326–2332. 16 indexed citations
19.
Pocock, Joanna, Joana C. Vasconcelos, & Andrew J.K. Östör. (2008). Assessment of anti-TNF-α efficacy in rheumatoid arthritis: is 3 months sufficient?. Lara D. Veeken. 47(7). 1073–1076. 12 indexed citations
20.
Hori, Satoshi, et al.. (2008). Patterns of complementary and alternative medicine use amongst outpatients in Tokyo, Japan. BMC Complementary and Alternative Medicine. 8(1). 14–14. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026